Literature DB >> 21474761

Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA.

Patrick Edery1, Charles Marcaillou, Mourad Sahbatou, Audrey Labalme, Joelle Chastang, Renaud Touraine, Emmanuel Tubacher, Faiza Senni, Michael B Bober, Sheela Nampoothiri, Pierre-Simon Jouk, Elisabeth Steichen, Siren Berland, Annick Toutain, Carol A Wise, Damien Sanlaville, Francis Rousseau, Françoise Clerget-Darpoux, Anne-Louise Leutenegger.   

Abstract

The spliceosome, a ribonucleoprotein complex that includes proteins and small nuclear RNAs (snRNAs), catalyzes RNA splicing through intron excision and exon ligation to produce mature messenger RNAs, which, in turn serve as templates for protein translation. We identified four point mutations in the U4atac snRNA component of the minor spliceosome in patients with brain and bone malformations and unexplained postnatal death [microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) or Taybi-Linder syndrome (TALS); Mendelian Inheritance in Man ID no. 210710]. Expression of a subgroup of genes, possibly linked to the disease phenotype, and minor intron splicing were affected in cell lines derived from TALS patients. Our findings demonstrate a crucial role of the minor spliceosome component U4atac snRNA in early human development and postnatal survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474761     DOI: 10.1126/science.1202205

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  87 in total

1.  Inferring coancestry in population samples in the presence of linkage disequilibrium.

Authors:  M D Brown; C G Glazner; C Zheng; E A Thompson
Journal:  Genetics       Date:  2012-01-31       Impact factor: 4.562

2.  Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes.

Authors:  Elina H Niemelä; Jens Verbeeren; Prosanta Singha; Visa Nurmi; Mikko J Frilander
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 3.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

Review 4.  Emerging mechanisms and consequences of calcium regulation of alternative splicing in neurons and endocrine cells.

Authors:  Aleh Razanau; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2013-06-26       Impact factor: 9.261

Review 5.  Identity by descent: variation in meiosis, across genomes, and in populations.

Authors:  Elizabeth A Thompson
Journal:  Genetics       Date:  2013-06       Impact factor: 4.562

Review 6.  Advances in Skeletal Dysplasia Genetics.

Authors:  Krista A Geister; Sally A Camper
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

7.  Microcephalic osteodysplastic primordial dwarfism type I with biallelic mutations in the RNU4ATAC gene.

Authors:  R Nagy; H Wang; B Albrecht; D Wieczorek; G Gillessen-Kaesbach; E Haan; P Meinecke; A de la Chapelle; J A Westman
Journal:  Clin Genet       Date:  2011-08-28       Impact factor: 4.438

8.  RNA Binding Motif Protein 48 Is Required for U12 Splicing and Maize Endosperm Differentiation.

Authors:  Fang Bai; Jacob Corll; Donya N Shodja; Ruth Davenport; Guanqiao Feng; Janaki Mudunkothge; Christian J Brigolin; Federico Martin; Gertraud Spielbauer; Chi-Wah Tseung; Amy E Siebert; W Brad Barbazuk; Shailesh Lal; A Mark Settles
Journal:  Plant Cell       Date:  2019-02-13       Impact factor: 11.277

Review 9.  Pre-mRNA splicing in disease and therapeutics.

Authors:  Ravi K Singh; Thomas A Cooper
Journal:  Trends Mol Med       Date:  2012-07-18       Impact factor: 11.951

Review 10.  Non-coding RNAs and disease: the classical ncRNAs make a comeback.

Authors:  Rogerio Alves de Almeida; Marcin G Fraczek; Steven Parker; Daniela Delneri; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.